US 7,550,275 B2
Expression, purification and uses of a Plasmodium falciparum liver stage antigen 1 polypeptide
David E. Lanar, Takoma Park, Md. (US); Collette J. Hillier, Concord (Australia); Jeffrey A. Lyon, Accident, Md. (US); Evelina Angov, Bethesda, Md. (US); Sanjai Kumar, Gaithersburg, Md. (US); William Rogers, Jakata (Indonesia); and Arnoldo Barbosa, Tolima (Colombia)
Assigned to The United States of America as represented by the Secretary of the Navy, Washington, D.C. (US)
Filed on Nov. 12, 2003, as Appl. No. 10/706,435.
Claims priority of provisional application 60/425719, filed on Nov. 12, 2002.
Prior Publication US 2006/0088547 A1, Apr. 27, 2006
Int. Cl. C12N 15/00 (2006.01); A61K 39/015 (2006.01); C07K 14/445 (2006.01)
U.S. Cl. 435—69.1  [435/7.1; 424/191.1; 530/350] 17 Claims
 
1. A purified recombinant polypeptide LSA-NRC(H) specified in SEQ ID NO:26.